Search

everythinglearnresearchcommunity

for

Search:↓

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Finasteride reduces hair growth and is safe for women with excessive hair.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Finasteride may help some women with hair loss, but better options exist.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

Machine learning can accurately diagnose PCOS non-invasively using clinical and ultrasound features.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.

Secondary amenorrhea has many causes and requires thorough evaluation to treat and restore menstrual cycles.